213 related articles for article (PubMed ID: 27062639)
1. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
Shan N; Xu PF
Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
[TBL] [Abstract][Full Text] [Related]
2. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
Chiba Y
Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
[TBL] [Abstract][Full Text] [Related]
3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
4. Large sample bounds on the survivor average causal effect in the presence of a binary covariate with conditionally ignorable treatment assignment.
Freiman MH; Small DS
Int J Biostat; 2014; 10(2):143-63. PubMed ID: 25294716
[TBL] [Abstract][Full Text] [Related]
5. Alternative monotonicity assumptions for improving bounds on natural direct effects.
Chiba Y; Taguri M
Int J Biostat; 2013 Jul; 9(2):235-49. PubMed ID: 23893690
[TBL] [Abstract][Full Text] [Related]
6. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
Chiba Y; Sato T; Greenland S
Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
[TBL] [Abstract][Full Text] [Related]
7. Non-parametric bounds on treatment effects with non-compliance by covariate adjustment.
Cai Z; Kuroki M; Sato T
Stat Med; 2007 Jul; 26(16):3188-204. PubMed ID: 17136775
[TBL] [Abstract][Full Text] [Related]
8. An introduction to spillover effects in cluster randomized trials with noncompliance.
Keele L; Kang H
Clin Trials; 2022 Aug; 19(4):375-379. PubMed ID: 35510562
[TBL] [Abstract][Full Text] [Related]
9. Sharpening bounds on principal effects with covariates.
Long DM; Hudgens MG
Biometrics; 2013 Dec; 69(4):812-9. PubMed ID: 24245800
[TBL] [Abstract][Full Text] [Related]
10. Estimating causal effects of treatment in RCTs with provider and subject noncompliance.
Sheng E; Li W; Zhou XH
Stat Med; 2019 Feb; 38(5):738-750. PubMed ID: 30347462
[TBL] [Abstract][Full Text] [Related]
11. Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity.
Yin Y; Cai Z; Zhou XH
Biom J; 2018 Sep; 60(5):879-892. PubMed ID: 29911355
[TBL] [Abstract][Full Text] [Related]
12. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
Boatman JA; Vock DM; Koopmeiners JS
Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
[TBL] [Abstract][Full Text] [Related]
13. Instruments and bounds for causal effects under the monotonic selection assumption.
Taguri M; Chiba Y
Int J Biostat; 2012 Aug; 8(1):24. PubMed ID: 22944723
[TBL] [Abstract][Full Text] [Related]
14. The effects of treatment noncompliance on power in a 2 x 2 factorial design.
Lindblad AS
J Biopharm Stat; 1996 Jul; 6(3):263-70. PubMed ID: 8854231
[TBL] [Abstract][Full Text] [Related]
15. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
Chiba Y
Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
[TBL] [Abstract][Full Text] [Related]
16. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
O'Malley AJ; Normand SL
Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
[TBL] [Abstract][Full Text] [Related]
17. Using survival information in truncation by death problems without the monotonicity assumption.
Yang F; Ding P
Biometrics; 2018 Dec; 74(4):1232-1239. PubMed ID: 29665626
[TBL] [Abstract][Full Text] [Related]
18. Handling missing data in randomized experiments with noncompliance.
Jo B; Ginexi EM; Ialongo NS
Prev Sci; 2010 Dec; 11(4):384-96. PubMed ID: 20379779
[TBL] [Abstract][Full Text] [Related]
19. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
Small DS; Cheng J
Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
[No Abstract] [Full Text] [Related]
20. Applying optimal model selection in principal stratification for causal inference.
Odondi L; McNamee R
Stat Med; 2013 May; 32(11):1815-28. PubMed ID: 23042517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]